Sector: Pharmaceuticals & Biotechnology

Large Cap

Ipca Laboratories Share Price

Ipca Laboratories Ltd.

₹1,469.70

19.90(1.37%)

Invest in IPCALAB with up to 2.86x margin.

Trade with MTF

23rd Feb 2026 | 3:28 PM

NSE : IPCALAB

Open Free Demat Account

Ipca Laboratories Performance

Price Movement

₹1469.70

₹1465.00

₹1501.00

↘ Today's Low↗ Today's High

1 Year Performance

₹1469.70

₹1168.20

₹1595.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹1,501.00

Low₹1,465.00

Open at₹1,465.00

Prev Close₹1,449.80

Volumes2.29 L

Avg Price₹1,479.41

Lower Circuit₹1,159.90

Upper Circuit₹1,739.70

Historical Performance

3M High₹1,582.60

3M Low₹1,361.70

1 Yr High₹1,595.00

1 Yr Low₹1,168.20

3 Yr High₹1,755.90

3 Yr Low₹669.80

5 Yr High₹1,755.90

5 Yr Low₹669.80

Ipca Laboratories Fundamentals

Market Cap

High in industry

37,388.40 Cr.

PE Ratio (TTM)

Above industry Median

41.10

Dividend Yield

Low in industry

0.10

Net Profit TTM

24.7% incr over last year

909.87

Net Profit Growth

24.7% incr over last year

909.87

PEG Ratio

High in industry

1.70

ROE

22.8% incr over last year

10.61

Operating Revenue TTM

9,504.54

Operating Revenue Growth

8.9% incr over last year

Book Value

Above industry Median

MFI

MFI is mid-range

53.68

RSI

RSI is mid-range

47.96

EPS (TTM)

35.14

Debt to Equity

0.19

Face Value

Operating Profit Margin Qtr.

19.11

Operating Profit Qtr.

533.35

Net Profit Qtr.

326.27

Operating Revenue Qtr.

2,392.50

PB Ratio

Ipca Laboratories Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	1,845.18	1,930.32	1,746.90	1,638.44	1,662.68
Operating Expense	1,367.70	1,465.61	1,339.98	1,279.85	1,251.59
Operating Profit	477.48	464.71	406.92	358.59	411.09
Depreciation	68.57	66.86	63.13	65.19	62.81
Interest	9.51	11.46	12.06	16.20	10.17
Tax	113.77	103.57	94.71	82.20	87.96
Net Profit	303.45	304.74	262.04	-65.05	267.56

IPCALAB Stock Recommendation by HDFC

View Call ↗

Research Type

Equity , Long Term

Buy Range

₹1,379 - ₹0

Target Price

₹1,750

Stop Loss

Target Date

23 Aug 26

Potential Returns

26.90 %

View Call ↗

Ipca Laboratories Technicals

Ipca Laboratories Ltd. EMA & SMA

₹1469.70

19.90 (1.37%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹1467.3

Day EMA10 ₹1465.4

Day EMA12 ₹1464.3

Day EMA20 ₹1461.9

Day EMA26 ₹1460.5

Day EMA50 ₹1450.3

Day EMA100 ₹1430.5

Day EMA200 ₹1416.1

Ipca Laboratories Support and Resistance

Resistance

First Resistance₹1464.47

Second Resistance₹1479.13

Third Resistance₹1493.27

Support

First Support₹1435.67

Second Support₹1421.53

Third Support₹1406.87

Technical Indicators

Day RSI47.96

Day MFI53.68

Day ADX13.92

Day Commodity Channel Index-9.70

William-58.24

Day MACD3.84

Day MACD Signal Line1.84

Day ATR51.24

Day ROC1256.67

Day ROC21-2.41

Ipca Laboratories Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	46.3	44.7	44.7	44.7	44.7	44.7
FII	10.8	11.1	10.8	10.7	10.4	10.6
DII	34.2	35.6	36	36.2	36.8	37.3
Public	8.6	8.5	8.4	8.4	8.1	7.3

Ipca Laboratories Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	1.59 L	2.09 L	75.81%
Week	1.77 L	2.58 L	68.62%
1 Month	1.19 L	2.17 L	54.79%
6 Month	1.24 L	2.63 L	47.03%

Ipca Laboratories SWOT Analysis

Strengths25

Weakness4

Opportunity10

Threats1

Positive Breakout First Resistance ( LTP > R1)

Benjamin Graham Value Screen

Strong Performer, Getting Expensive (DVM)

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Newly Affordable Stocks with Good Financials and Durability (subscription)

Strong Momentum: Price above short, medium and long term moving averages

Rising Net Cash Flow and Cash from Operating activity

Companies with high TTM EPS Growth

Growth Stars: Strongest Annual EPS Performers

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing profits every quarter for the past 3 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Companies with Zero Promoter Pledge

High Volume, High Gain

Top Gainers

Volume Shockers

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Ipca Laboratories Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
05 Aug, 2025	2	FINAL	05 Aug, 2025	Equity Share
25 Nov, 2024	2	INTERIM	25 Nov, 2024	Equity Share
06 Aug, 2024	2	FINAL		Equity Share
22 Nov, 2023	2	INTERIM	22 Nov, 2023	Equity Share
22 Nov, 2022	4	INTERIM	23 Nov, 2022	Equity Share
22 Nov, 2021	8	INTERIM	23 Nov, 2021	Equity Share
13 Nov, 2020	8	INTERIM	17 Nov, 2020	Equity Share
18 Feb, 2020	5	INTERIM	20 Feb, 2020	Equity Share
06 Aug, 2019	3	FINAL		Equity Share
02 Aug, 2018	1	FINAL		Equity Share

Ipca Laboratories Stock Comparison

Financials	Anthem Biosciences Ltd.	Emcure Pharmaceuticals Ltd.	Mankind Pharma Ltd.	Piramal Pharma Ltd.	Gland Pharma Ltd.	Laurus Labs Ltd.
Price (₹)	₹696.90	₹1,431.80	₹2,045	₹162	₹1,803	₹1,014.60
% Change	2.20%	-0.42%	1.02%	0.92%	-1.03%	-0.43%
Revenue TTM (₹ Cr)	₹1,996.59	₹8,850.08	₹13,914.08	₹8,871.37	₹6,112.77	₹6,721.63
Net Profit TTM (₹ Cr)	₹484.66	₹869.92	₹1,779.35	₹-163.61	₹847.18	₹843.32
PE TTM	80.70	31.30	47.50	-131.70	35.10	65.10
1 Year Return	22.17	44.17	-12.08	-22.44	18.09	95.04
ROCE	26.88	20.80	13.27	6.40	11.43	11.82

Similar Stocks

ALKEM

Alkem Laboratories Ltd.

₹ 5487.00

+1.76%

BIOCON

Biocon Ltd.

₹ 388.00

+1.05%

DIVISLAB

Divi's Laboratories Ltd.

₹ 6258.50

-0.52%

AJANTPHARM

Ajanta Pharma Ltd.

₹ 2975.00

+1.21%

ZYDUSLIFE

Zydus Lifesciences Ltd.

₹ 905.30

GLENMARK

Glenmark Pharmaceuticals Ltd.

₹ 2033.00

-0.50%

WOCKPHARMA

Wockhardt Ltd.

₹ 1370.00

-0.84%

AUROPHARMA

Aurobindo Pharma Ltd.

₹ 1148.70

-0.87%

SUNPHARMA

Sun Pharmaceutical Industries Ltd.

₹ 1732.00

+0.44%

JBCHEPHARM

J B Chemicals & Pharmaceuticals Ltd.

₹ 2051.00

+2.53%

ASTRAZEN

AstraZeneca Pharma India Ltd.

₹ 8807.00

-0.93%

GLAXO

GlaxoSmithKline Pharmaceuticals Ltd.

₹ 2635.30

+1.48%

PFIZER

Pfizer Ltd.

₹ 5066.60

+2.74%

ABBOTINDIA

Abbott India Ltd.

₹ 26425.00

+0.49%

TORNTPHARM

Torrent Pharmaceuticals Ltd.

₹ 4318.50

+1.81%

LUPIN

Lupin Ltd.

₹ 2241.00

+0.97%

DRREDDY

Dr. Reddy's Laboratories Ltd.

₹ 1305.10

+1.93%

CIPLA

Cipla Ltd.

₹ 1327.00

-1.05%

FAQ's on IPCALAB

What is the current share price of Ipca Laboratories Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Ipca Laboratories Ltd. is ₹ 1469.7 on the NSE and ₹ 1468.5 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Ipca Laboratories Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Ipca Laboratories Ltd. is approximately ₹ 37388.4 Cr.

What are the PE and PB ratios for Ipca Laboratories Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Ipca Laboratories Ltd. is 41.1, and the Price-to-Book (PB) ratio is 5.

What is the 52-Week High and Low for Ipca Laboratories Ltd.?

Over the past 52 weeks, the highest price reached by Ipca Laboratories Ltd. shares was ₹ 1595, and the lowest price was ₹ 1168.2.

What is the current dividend yield for Ipca Laboratories Ltd.?

As of 6 June 2025, the dividend yield for Ipca Laboratories Ltd. is 0.1%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Ipca Laboratories Ltd.?

Significant shareholdings in Ipca Laboratories Ltd. typically include entities such as:

Promoter
Mutual Funds
FII
Public
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Ipca Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Ipca Laboratories Ltd. is often compared with other major players such as Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies, Sudeep Pharma and Curis Lifesciences for analysis and benchmarking.

What is the latest dividend information for Ipca Laboratories Ltd.?

Ipca Laboratories Ltd. last declared a FINAL dividend of ₹ 2 per share for the financial period ending 2025. The record date was set as 2025-08-05, and the payment was/is scheduled around 2025-08-05. For the most current dividend announcements, refer to official company filings.